Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAAOI-2 add-on for treatment-resistant schizophrenia
NCT02532686Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium cinnamate in schizophrenia, sponsored by China Medical University Hospital. Started Oct 2014; status: completed.
02
Drugs
sodium cinnamate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02532686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532686.